| 19 Insights into geographically targeted hepatitis B secondary prevention in the UK A O'Ferrall, A West, M Bell, G Walker, D Norton, G Ferrier, N Easom Abstracts Clinical Infection in Practice 15, 100161, 2022 | | 2022 |
| 36 Misdiagnoses in the context of suspected pandemic influenza or COVID-19: A systematic review L Bray, K Meznikova, D James, P Mason, R Rislan, R Shah, T Staniland, ... Clinical Infection in Practice 15, 100197, 2022 | 1 | 2022 |
| 68 Uncommon culprit: Can Staphylococcus epidermidis be a cause of native valve infective endocarditis in an injecting drug user? M Muddassir, K Elgizouli, N Easom, A Khalid Clinical Infection in Practice 20, 100321, 2023 | | 2023 |
| 7 Differences in physiological/metabolic parameters and mortality between people who inject drugs (PWID) and non PWID, with Staphylococcus aureus blood stream infection; A … I Mortimer, S Lowe, K Drury, M Akhtar, N Easom, P Lillie Clinical Infection in Practice 15, 100168, 2022 | | 2022 |
| A psychiatric diagnosis overturned by a blood film E Wise, N Easom, J Watson, R Bailey, M Brown Clinical medicine 12 (3), 295, 2012 | 4 | 2012 |
| Accuracy of the Mologic COVID-19 rapid antigen test: a prospective multi-centre analytical and clinical evaluation A CubasAtienzar, F Bell, R Byrne, K Buist, DJ Clark, M Cocozza, A Collins, ... Wellcome Open Research 6, 132, 2021 | 5 | 2021 |
| Acute Epstein-Barr infection presenting as cholecystitis with ascites KT Lamprianidis, N Easom, E Patch, S Thomas BMJ Case Reports CP 13 (1), e232562, 2020 | 3 | 2020 |
| ASSESSMENT OF THE EFFECTIVENESS AND UTILITY OF THE NEW WHO GUIDELINES FOR THE MANAGEMENT OF HEPATITIS B IN NORTHERN UGANDA N Easom, N Laing, H Tufton, E Ochola, A Elliot, M Maini AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 93 (4), 131-131, 2015 | | 2015 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 321 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 236 | 2022 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group, PW Horby, M Mafham, L Peto, M Campbell, G Pessoa-Amorim, ... MedRxiv, 2021.06. 15.21258542, 2021 | 372* | 2021 |
| chain reaction (PCR) and LFD positivity across symptomatic and asymptomatic groups. PJ Lillie, P O’Brien, M Lawtie, S Jessop, NJW Easom, R Patmore Clinical Infectious Diseases 73 (10), 1906-8, 2021 | | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 311 | 2022 |
| Cohort profile: post-Hospitalisation COVID-19 (PHOSP-COVID) study O Elneima, HJC McAuley, OC Leavy, JD Chalmers, A Horsley, LP Ho, ... International Journal of Epidemiology 53 (1), dyad165, 2024 | 2 | 2024 |
| Cohort profile: post-hospitalisation COVID-19 study (PHOSP-COVID) O Elneima, HJC McAuley, OC Leavy, JD Chalmers, A Horsley, LP Ho, ... medRxiv, 2023.05. 08.23289442, 2023 | 3 | 2023 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 113 | 2021 |
| Correction to Lancet Respir Med 2021; 9: 1275–87 (The Lancet Respiratory Medicine (2021) 9 (11)(1275–1287),(S2213260021003830),(10.1016/S2213-2600 (21) 00383-0)) RA Evans, H McAuley, A Shikotra, A Singapuri, M Sereno, O Elneima, ... The Lancet Respiratory Medicine 10 (1), e9-e9, 2021 | | 2021 |
| Cutaneous thigh abscess secondary to melioidosis: a rare cause for a common presentation S Hughes, F Loughenbury, A Richards, N Easom BMJ Case Reports 14 (3), 2021 | 1 | 2021 |
| Demographics and outcomes of initial phase of COVID-19 medicines delivery units across 4 UK centers during peak B1. 1.529 Omicron epidemic: a service evaluation M Brown, J Saund, A Qureshi, M Plowright, K Drury, J Gahir, T Simpson, ... Open forum infectious diseases 9 (10), ofac527, 2022 | 6* | 2022 |
| Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls B Zheng, G Vivaldi, L Daines, OC Leavy, M Richardson, O Elneima, ... The Lancet Regional Health–Europe 29, 2023 | 12 | 2023 |
